Correlation Between Century Therapeutics and NetScout Systems

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Century Therapeutics and NetScout Systems at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Century Therapeutics and NetScout Systems into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Century Therapeutics and NetScout Systems, you can compare the effects of market volatilities on Century Therapeutics and NetScout Systems and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Century Therapeutics with a short position of NetScout Systems. Check out your portfolio center. Please also check ongoing floating volatility patterns of Century Therapeutics and NetScout Systems.

Diversification Opportunities for Century Therapeutics and NetScout Systems

-0.23
  Correlation Coefficient

Very good diversification

The 3 months correlation between Century and NetScout is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Century Therapeutics and NetScout Systems in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NetScout Systems and Century Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Century Therapeutics are associated (or correlated) with NetScout Systems. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NetScout Systems has no effect on the direction of Century Therapeutics i.e., Century Therapeutics and NetScout Systems go up and down completely randomly.

Pair Corralation between Century Therapeutics and NetScout Systems

Given the investment horizon of 90 days Century Therapeutics is expected to under-perform the NetScout Systems. In addition to that, Century Therapeutics is 2.54 times more volatile than NetScout Systems. It trades about -0.05 of its total potential returns per unit of risk. NetScout Systems is currently generating about 0.11 per unit of volatility. If you would invest  1,967  in NetScout Systems on September 16, 2024 and sell it today you would earn a total of  271.00  from holding NetScout Systems or generate 13.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Century Therapeutics  vs.  NetScout Systems

 Performance 
       Timeline  
Century Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Century Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
NetScout Systems 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in NetScout Systems are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile fundamental indicators, NetScout Systems unveiled solid returns over the last few months and may actually be approaching a breakup point.

Century Therapeutics and NetScout Systems Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Century Therapeutics and NetScout Systems

The main advantage of trading using opposite Century Therapeutics and NetScout Systems positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Century Therapeutics position performs unexpectedly, NetScout Systems can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NetScout Systems will offset losses from the drop in NetScout Systems' long position.
The idea behind Century Therapeutics and NetScout Systems pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges